Biotec Pharmacon has received approval from the Financial Supervisory Authority of Norway (Finanstilsynet) on the following prospectus:

Listing of 3,500,000 Shares on Oslo Børs, each with a nominal value of NOK 1.00, issued in connection with an already completed Private Placement at a subscription price of NOK 6.30 per share, raising gross proceeds of NOK 22,050,000.

This prospectus serves as a listing prospectus and no shares or other securities are being offered or sold in any jurisdiction pursuant to this prospectus. The new shares are expected to be listed on or about 7 January 2011, following the registration of the new shares. The new shares issued in the private placement can not be traded until the new shares have been issued.

Date of prospectus: 5 January 2011.

The prospectus is available at Biotec Pharmacon, Strandgata 3, 9008 Tromsø, Norway, from 7 January 2011. Prospectus link.

The prospectus is also available at www.sebenskilda.no.